BioNTech SE (BNTX): Why analyst showing interest


BioNTech SE (NASDAQ:BNTX) changes shares on Tuesday trading session, with a change of -8.18% or -$4.7 shares. The trading starts at $55.62 and closed at $57.45 throughout the day. The trading session low price was $51.52 and day high was $56.00 on Tuesday, June 23. After the session, the Healthcare sector daily volume shifted to 2.13 million while its average volume is 1.35M. In other hand, the BNTX market cap reached to $11.96B. While, its current target price is $52.75 according to WSJ.

Checking out the performance report which defines the increase or decrease of prices for a specific period. For the last 5 trading sessions, its performance is up 5.71% and up 3.37% for month. Its quarterly performance was -1.66% below, while its half year performance is up 50.84%. BNTX performance rise 55.70% for year-to-date. Current recommendation for BioNTech SE is 2.40.

Earnings per share or EPS is an important financial measure, which defines the profitability of a company. BNTX EPS (TTM) for 12-month is -0.57. EPS for this year is -300.50%, while for the next year its value is -0.76.

Let’s take a look on the analyst recommendations on BNTX for the current month and previous month. For the current month, 3 of 8 analysts recommend stock as Buy while 0 as Sell, 0 as overweight, 0 as underweight and 5 as Hold. As compared with the previous month ratings, 9 analysts participate in stock recommendation. Out of 9, 0 rated it sell, 3 rated it as Buy and 6 as Hold Ratings. On the other hand, target price ranges from $28.00-$69.00. Average target price for BNTX was reached at $45.77.

Primecap Management Company, Artal Group S.A. and FMR, LLC are the top three holders in BioNTech SE (BNTX) stock. On Mar 30, 2020, Primecap Management Company has 2.61 million shares which valued 152.55 million. On Mar 30, 2020, Artal Group S.A. owned 2.23 million shares which valued at 130.12 million. On Mar 30, 2020, FMR, LLC has a total of 0.74 million shares which valued at 43.11 million. In the end, FMR, LLC have 5.59% shares outstanding of BioNTech SE (BNTX) on Mar 30, 2020. The insider ownership moved to 1.26% and institutional holding shifted to 3.30%.

The company posted an EPS (TTM) of -0.57. According to the most recent quarter report on (Mar 2020), 6 analysts estimated an average EPS of -0.25. Analyst Estimated EPS for BNTX published in the report was -0.28–0.16 during the same period.

A brief look on simple moving average (SMA) that determines the market price can impact a market. The SMA for BNTX rise 43.39% for period of 200 days. SMA for 50 days was 8.42% which is showing green signal, while SMA-20 was 5.25%. The moving average value for BioNTech SE (BNTX) is 42.25 and 50.21 for 200 and 50 days respectively.